98%
921
2 minutes
20
Objectives: The primary objective in this study is to determine the sensitivity and specificity of a two-item screening interview for depression versus the formal psychiatric interview, in the setting of a specialist palliative in-patient unit so that we may identify those individuals suffering from depressive disorder and therefore optimise their management in this often-complex population.
Methods: A prospective sample of consecutive admissions (n = 167) consented to partake in the study, and the screening interview was asked separately to the formal psychiatric interview.
Results: The two-item questionnaire, achieved a sensitivity of 90.7% (95% CI 76.9-97.0) but a lower specificity of 67.7% (95% CI 58.7-75.7). The false positive rate was 32.3% (95% CI 24.3-41.3), but the false negative rate was found to be a low 9.3% (95% CI 3.0-23.1). A subgroup analysis of individuals with a past experience of depressive illness, (n = 95), revealed that a significant number screened positive for depression by the screening test, 55.2% (16/29) compared to those with no background history of depression, 33.3% (22/66) (P = 0.045).
Conclusion: The high sensitivity and low false negative rate of the two-question screening tool will aid health professionals in identifying depression in the in-patient specialist palliative care unit. Individuals, who admit to a previous experience of depressive illness, are more likely to respond positively to the two-item questionnaire than those who report no prior history of depressive illness (P = 0.045).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0269216307077315 | DOI Listing |
J Hosp Palliat Nurs
September 2025
Kimberly A. Pyke-Grimm, PhD, RN, CNS, CPHON, is nurse scientist, Department of Nursing Research and Evidence-Based Practice, Center for Professional Excellence and Inquiry, Stanford Children's Health, Palo Alto, CA, and clinical assistant professor, Department of Pediatrics, Division of Hematology,
Patients undergoing hematopoietic stem cell transplant are at risk for significant morbidity and mortality throughout their treatment course. The aim of this evidence-based practice project was to determine if the use of a palliative care trigger tool impacted the number of palliative care consults and/or the early integration of palliative care services within the pediatric hematopoietic stem cell transplant patient population. A trigger tool was developed to identify patients at highest risk for stem cell transplant-associated morbidity and mortality.
View Article and Find Full Text PDFPalliat Med Rep
April 2025
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Background: Collaborative methods are necessary to meet patient palliative care (PC) needs because of the inadequate supply of PC specialists.
Objective: This study aimed to conduct a needs assessment and determine primary care, emergency, and hospital physicians' general attitudes about primary PCs, confidence in managing common PC scenarios, and preferences for interaction with specialty PCs.
Design: A sequential mixed-methods study design was used, whereby individual qualitative interviews informed the content of a quantitative survey.
Palliat Med Rep
April 2025
Department of Oncology, King Faisal Specialist Hospital & Research Centre (KFSH&RC), Jeddah, Saudi Arabia.
Background And Aims: Palliative radiotherapy practice patterns have been reported to vary widely, with a notable underutilization of single fraction treatment schedules. This study aims to investigate the outcomes and care patterns among patients receiving palliative radiotherapy for advanced cancer at a high-volume institution in Saudi Arabia.
Materials And Methods: Electronic records were used to identify patients receiving palliative radiotherapy for advanced cancer between 2018 and 2023.
Br J Nurs
September 2025
Senior Director Medical and Clinical Affairs, Convatec Technology Centre, Deeside, UK.
Background: The Neria™ Guard infusion set is indicated for the infusion of several medications for Parkinson's and pain-management therapy.
Aim: The aim of this study was to explore the impact of the Neria Guard infusion set on patients and health professionals from the perspective of nurses.
Method: Two surveys were distributed to nurses: one targeting nurses who use Neria Guard for Parkinson's patients, and one for those who use it for palliative care patients.
Br J Nurs
September 2025
Macmillan Palliative and End of Life Care Practice Educator and Specialist Nurse Practitioner, Northampton General Hospital.
For individuals with diabetes, maintaining optimal glycaemic control is essential to reduce the risk of long-term complications. However, as patients approach the end of life, the emphasis on tight glycaemic targets becomes less relevant. Instead, the primary goal shifts to maintaining blood glucose levels within a range that minimises the risk of hypoglycaemia and prevents symptomatic hyperglycaemia, thereby ensuring comfort and quality of life.
View Article and Find Full Text PDF